arrow
K

Kai Shen

West China Hospital
H指数:21
被引数:1,649

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dose modifications, discontinuation patterns and PFS of zanubrutinib in 410 CLL/SLL patients – a nationwide real-world cohort

奥布替尼在410例CLL/SLL患者中的剂量调整、停药模式和无进展生存期——一项全国性真实世界队列研究

2026-09-290
OAAI
Mecapegfilgrastim for Prophylaxis of Immunochemotherapy-Induced Neutropenia in Patients With Diffuse Large B-Cell Lymphoma: A Multicenter Pilot Trial

美卡波非格司亭预防弥漫性大B细胞淋巴瘤患者免疫化疗诱导的中性粒细胞减少症:一项多中心试点试验

2026-04-240
OAAI
Venetoclax plus decitabine, cytarabine, aclarubicin, and G-CSF in adults with newly diagnosed acute myeloid leukemia: A multicenter, retrospective study

维奈克拉 plus decitabine, cytarabine, aclarubicin, and G-CSF 在新诊断急性髓系白血病的成人中的研究:一项多中心、回顾性研究

2025-11-010
PRE
Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebocontrolled, dose-escalation phase 1 trial
2023-04-053
OAAI